Nkarta (NKTX) Stock: Buy, Sell, or Hold?
$1.48
+0.13 (+9.63%)
▲
5d:
-14.45%
30d:
-29.52%
90d:
-35.65%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (63%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$1.53 – $2.12
Position: OVERSOLD
Forward P/E & Valuation
-1.0x
Next 12M consensus est.
Wall Street Target
$10.50
+609.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.13 / $1.84
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: NKTX is down 14.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When NKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NKTX is currently trading at $1.48, which is considered oversold relative to its 30-day fair value range of $1.53 to $2.12.
Technical Outlook: Technically, NKTX is in a downtrend. Immediate support is located at $1.13, while resistance sits at $1.84. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: NKTX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.50 (+609.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NKTX is in a downtrend. Immediate support is located at $1.13, while resistance sits at $1.84. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: NKTX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.50 (+609.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.53 -
$2.12
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
Trading Range & Key Levels
30-Day Trading Range
$1.53 -
$2.12
Current vs Trading Range
OVERSOLD
Support Level
$1.13
Resistance Level
$1.84
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.6%)
- BULLISH: Trading 609.5% below Wall St target ($10.50)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.98
Wall Street Target
$10.50
(+609.5%)
Share NKTX Analysis
Share this live NKTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NKTX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits buzzes with bullish sentiment as traders express confusion over recent sell-offs in Nkarta ($NKTX) and Fate Therapeutics ($FATE), despite positive data releases.
Key Retail Themes:
market reaction
positive data
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 34 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NKTX Research Pages
